Peder Cedervall

Peder Cedervall is a Senior Director and Structural Biology Leader at Eli Lilly, where they utilize their expertise in macromolecular crystallography and structure-guided ligand design. With a strong background in the gene-to-structure determination process, Peder has been integral to various multidisciplinary drug discovery teams throughout their career. Prior to their current role, they worked as a Senior Principal Scientist at Loxo Oncology and held multiple scientific positions at esteemed organizations such as Pfizer and Dart NeuroScience LLC. Peder earned a PhD in Biochemistry, Molecular Biology, and Biophysics from the University of Minnesota after obtaining an M.Sc. in Chemical Biology from Linköping University.